200
Views
39
CrossRef citations to date
0
Altmetric
Original Research

Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations

, , , , , , , , & show all
Pages 975-990 | Published online: 16 Feb 2018

References

  • DavaranSRashidiMRPourabbasBDadashzadehMHaghsheansNMAdriamycin release from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles: synthesis and in vitro characterizationInt J Nanomed200614535539
  • AdibkiaKJavadzadehYDastnakchiSMohammadiGNiriFKBeiramiMANaproxen eudragit RS 100 nanoparticles: preparation and physiochemical characterizationColloids Surf B201183155159
  • NaharMMishraDDubeyVJainNKDevelopment characterization and toxicity evaluation of amphotericin B loaded gelatine nanoparticlesNanomedicine2008425226118502187
  • ArmstrongBDollREnvironmental factors and cancer incidence and mortality in different countries, with special reference to dietary practicesInt J Cancer19751546176311140864
  • FujiokaTKashiwadaYKilkuskieREAnti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoidsJ Nat Prod19945722432478176401
  • MayauxJFBousseauAPauwelsRTriterpene derivatives that block entry of human immunodeficiency virus type 1 into cellsProc Natl Acad Sci U S A1994919356435688170948
  • AdamsonCSWakiKAblanSDSalzwedelKFreedEOImpact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457)J Virol2009834884489419279107
  • FuldaSBetulinic acid for cancer treatment and preventionInt J Mol Sci200891096110719325847
  • WickWGrimmelCWagenknechtBDichgansJWellerMBetulinic acid-induced apoptosis in glioma cells: a sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processingJ Pharmacol Exp Ther199928931306131210336521
  • FuldaSJeremiasISteinerHHPietschTDebatinKMBetulinic acid: a new cytotoxic agent against malignant brain-tumor cellsInt J Cancer199982343544110399962
  • ZucoVSupinoRRighettiSCSelective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cellsCancer Lett20021751172511734332
  • ThurnherDTurhaniDPelzmannMBetulinic acid: a new cytotoxic compound against malignant head and neck cancer cellsHead Neck200325973274012953308
  • NodaYKaiyaTKohdaKKawazoeYEnhanced cytotoxicity of some triterpenes toward leukemia L1210 cells cultured in low pH media: possibility of a new mode of cell killingChem Pharm Bull (Tokyo)19974510166516709353895
  • EhrhardtHFuldaSFuhrerMDebatinKMJeremiasIBetulinic acid-induced apoptosis in leukemia cellsLeukemia20041881406141215201849
  • GopalDRNarkarAABadrinathYMishraKPJoshiDSBetulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-AblToxicol Lett2005155334335115649617
  • SelzerEPimentelEWacheckVEffects of betulinic acid alone and in combination with irradiation in human melanoma cellsJ Invest Dermatol2000114593594010771474
  • FuldaSBetulinic acid: a natural product with anticancer activityMol Nutr Food Res200953114014619065582
  • RieberMStrasbergRMInduction of p53 without increase in p21WAF1 in betulinic acid mediated cell death is preferential for human metastatic melanomaDNA Cell Biol1998173994069628583
  • WHOBurden: Mortality, Morbidity and Risk Factors931 Available from: http://www.who.int/nmh/publications/ncd_report_chapter1.pdfAccessed January 8, 2018
  • NewmanDJCraggGMSnaderKMNatural products as sources of new drugs over the period 1981–2002J Nat Prod20036671022103712880330
  • CraggGMNewmanDJSnaderKMNatural products in drug discovery and developmentJ Nat Prod199760152609014353
  • XuHRenXDuYStudy on absorption kinetics of betulic acid in rat’s intestinesZhongguo Zhong Yao Za Zhi201237337738022568244
  • RoyPDasSBeraTMondolSMukherjeeAAndrographolide nanoparticles in leishmaniasis: characterization and in vitro evaluationsInt J Nanomed2010511131121
  • El-SayKMMaximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper–Lin small composite designDrug Des Devel Ther201610825839
  • KeshariAKSinghAKRajVp-Tsa-promoted syntheses of 5h-benzo [h] thiazolo [2, 3-b] quinazoline and indeno [1, 2-d] thiazolo [3, 2-a] pyrimidine analogs: molecular modeling and in vitro antitumor activity against hepatocellular carcinomaDrug Des Devel Ther20171116231642
  • RoyPDasSMondalAChatterjiUMukherjeeANanoparticle engineering enhances anticancer efficacy of andrographolide in MCF-7 cells and mice bearing EACCurr Pharm Biotechnol201213152669268123072387
  • BhandariRKaurIPA sensitive HPLC method for determination of isoniazid in rat plasma, brain, liver and kidneyJ Chromatogr Sep Tech2012315
  • ConteJELinEZurlindenEHigh-performance liquid chromatographic determination of pyrazinamide in human plasma, bronchoalveolar lavage fluid, and alveolar cellsJ Chromatogr Sci2000381333710654790
  • MatsuzakiTMuraseNYagihashiALiver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in ratsTransplant Proc19922427487511373547
  • ShiotaGHaradaKIIshidaMInhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated miceCarcinogenesis199920159639934850
  • FurutaKSatoSMiyakeTAnti-tumor effects of cimetidine on hepatocellular carcinomas in diethylnitrosamine-treated ratsOncol Rep200819236136818202782
  • KeshariAKKumarGKushwahaPSIsolated flavonoids from Ficus racemosa stem bark possess antidiabetic, hypolipidemic and protective effects in albino Wistar ratsJ Ethnopharmacol201618125226226869543
  • LodhiRLMaitySKumarPSarafSAKaithwasGSahaSEvaluation of mechanism of hepatotoxicity of leflunomide using albino wistar ratsAfr J Pharm Pharmacol201372416251631
  • KushwahaPSRajVSinghAKAntidiabetic effects of isolated sterols from Ficus racemosa leavesRSC Adv20155443523035237
  • SahaSChanDSLeeCYPyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer propertiesEur J Pharmacol20126971–3132323041271
  • KumarPSinghAKRajV6, 7-dimethoxy-1, 2, 3, 4-tetrahydro-isoquinoline-3-carboxylic acid attenuates heptatocellular carcinoma in rats with NMR-based metabolic perturbationsFuture Sci OA201733FSO20228884001
  • KeshariAKSinghAKKumarU5H-benzo [h] thiazolo [2, 3-b] quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reductionDrug Des Devel Ther20171129812995
  • LiuWWangGYakovlevAGIdentification and functional analysis of the rat caspase-3 gene promoterJ Biol Chem2002277108273827811773055
  • LiCPLiJHHeSYLiPZhongXLRoles of Fas/Fasl, Bcl-2/Bax, and Caspase-8 in rat nonalcoholic fatty liver disease pathogenesisGenet Mol Res20141323991399924938610
  • JägerSLaszczykMNSchefflerAA preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betulae alba cortex)Molecules200813123224323519104487
  • Drag-ZalesinskaMKulbackaJSaczkoJEsters of betulin and betulinic acid with amino acids have improved water solubility and are selectively cytotoxic toward cancer cellsBioorganic Med Chem Lett2009191648144817
  • VandervoortJLudwigABiocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design studyInt J Pharm20022381–2779211996812
  • MurakamiHKawashimaYNiwaTHinoTTakeuchiHKobayashiMInfluence of the degrees of hydrolyzation and polymerization of poly (vinylalcohol) on the preparation and properties of poly (DL-lactide-co-glycolide) nanoparticleInt J Pharm199714914349
  • MullauerFBKesslerJHMedemaJPBetulin is a potent anti-tumor agent that is enhanced by cholesterolPLoS One200944e119399186
  • ZhangXHuJChenYBetulinic acid and the pharmacological effects of tumor suppression (Review)Mol Med Rep20161454489449527748864
  • Drąg-ZalesińskaMDrągMPorębaMBorskaSKulbackaJSaczkoJAnticancer properties of ester derivatives of betulin in human metastatic melanoma cells (Me-45)Cancer Cell Int20171711728053596
  • LiuYLuoWBetulinic acid induces Bax/Bak-independent cytochrome c release in human nasopharyngeal carcinoma cellsMol Cells201233551752422526391
  • SureshCZhaoHGumbsAChettyCSBoseHSNew ionic derivatives of betulinic acid as highly potent anti-cancer agentsBioorganic Med Chem Lett201222417341738
  • LiuHTHuangYCChengSBHuangYTLinPTEffects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: a randomized, placebo-controlled trialJ Nutr201615119
  • NewmanDJNatural products as leads to potential drugs: an old process or the new hope for drug discovery?J Med Chem20085192589259918393402
  • MakosBKYousonJHTissue levels of bilirubin and biliverdin in the sea lamprey, Petromyzon marinus L., before and after biliary atresiaComp Biochem Physiol A Physiol1988914701710
  • GreenRMFlammSAGA technical review on the evaluation of liver chemistry testsGastroenterology200212341367138412360498
  • YuMCChanKMLeeCFAlkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence?J Gastrointest Surg20111581440144921541770
  • IlamathiMPrabuPCAyyappaKASivaramakrishnanVArtesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signallingBiomed Pharmacother201682727927470341
  • XuHNKadlececkSProfkaHGlicksonJDRiziRLiLZIs higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized 13 C-pyruvateAcad Radiol201421222323124439336
  • WuHLiNJinRCytokine levels contribute to the pathogenesis of minimal hepatic encephalopathy in patients with hepatocellular carcinoma via STAT3 activationSci Rep201661928442746